Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia - CEPHEUS

Study identifier:NIS-CDZ-XXX-2012/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia

Medical condition

Hypercholesterolemia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1236

Study type

Observational

Age

19 Years - 150 Years

Date

Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Mar 2011
Study Completion Date: 01 Mar 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria